Article Information
History
- April 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Isaac Zentner1,
- Hyun-moon Back2,
- Leonid Kagan2,
- Selvakumar Subbian1,
- Jyothi Nagajyothi1,
- Shashikant Srivastava3,
- Jotam Pasipanodya3,
- Tawanda Gumbo3,
- Gregory P. Bisson4 and
- Christopher Vinnard1,*
- 1Public Health Research Institute, New Jersey Medical School, Newark, NJ, USA
- 2Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA
- 3Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX, USA
- 4University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
- ↵*Corresponding author: Christopher Vinnard, MD MPH MSCE, Public Health Research Institute, 225 Warren Street, Newark, NJ 07103, christopher.vinnard{at}njms.rutgers.edu
Posted April 17, 2020.
Redox imbalance and oxidative DNA damage during isoniazid treatment: A clinical and translational pharmacokinetic study
